ClinVar Miner

Submissions for variant NM_004519.4(KCNQ3):c.1709T>C (p.Met570Thr)

gnomAD frequency: 0.00001  dbSNP: rs199999939
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000712132 SCV000241583 uncertain significance not provided 2018-07-12 criteria provided, single submitter clinical testing p.Met570Thr (ATG>ACG): c.1709 T>C in exon 13 of the KCNQ3 gene (NM_004519.2) The M570T variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed with any significant frequency in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project. The M570T variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. The variant is found in EPILEPSY panel(s).
Athena Diagnostics Inc RCV000712132 SCV000842554 uncertain significance not provided 2018-07-10 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV001162487 SCV001324442 uncertain significance Seizures, benign familial neonatal, 2 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.
CeGaT Center for Human Genetics Tuebingen RCV000712132 SCV001746971 uncertain significance not provided 2021-06-01 criteria provided, single submitter clinical testing
Invitae RCV001852470 SCV002149560 uncertain significance Benign neonatal seizures 2022-06-05 criteria provided, single submitter clinical testing This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 570 of the KCNQ3 protein (p.Met570Thr). This variant is present in population databases (rs199999939, gnomAD 0.004%). This missense change has been observed in individual(s) with clinical features of KCNQ3-related conditions (PMID: 32086284). ClinVar contains an entry for this variant (Variation ID: 205975). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV002399698 SCV002713507 uncertain significance Inborn genetic diseases 2018-07-27 criteria provided, single submitter clinical testing The p.M570T variant (also known as c.1709T>C), located in coding exon 13 of the KCNQ3 gene, results from a T to C substitution at nucleotide position 1709. The methionine at codon 570 is replaced by threonine, an amino acid with similar properties. In one study of Rolandic epilepsy, this variant was detected in one of 567 controls, but absent in 194 patients (Bobbili DR et al. Eur. J. Hum. Genet., 2018 Feb;26:258-264). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.